Why You Feel Hungry All the Time on Wegovy — and What's Actually Going On

The myth: Wegovy should have killed your appetite by now

The most common misunderstanding our prescribers hear week after week goes something like this: "I've been on Wegovy for three weeks and I'm still hungry, is it working?" The assumption built into that question is that semaglutide flips a switch and hunger simply stops. It doesn't work that way, and the treatment wasn't designed to.

Wegovy's dose escalation exists precisely because the appetite effect strengthens as the dose rises. Starting at 0.25mg, moving through 0.5mg, 1mg and 1.7mg before reaching the 2.4mg maintenance dose takes around four months. At the lower rungs, most people notice relatively modest changes to how hungry they feel. That's expected. The experience of still feeling hungry on Wegovy at the beginning of treatment is the norm, not a sign something has gone wrong.

It's also worth understanding what semaglutide actually does to hunger. It acts on GLP-1 receptors involved in appetite signalling and slows how quickly the stomach empties, which prolongs the sense of fullness after eating. But it doesn't eliminate the biological drive to eat. Physical hunger, emotional eating, habit-driven eating and boredom are separate things, and only one of them is directly modulated by the medicine. Knowing which kind of hunger you're experiencing helps you respond to it more usefully than simply waiting for it to pass.

The NHS medicines guidance for semaglutide outlines the escalation schedule and explains the mechanism; it's worth reading alongside your patient information leaflet.

Which type of hunger are you actually dealing with?

This distinction matters practically. Physical hunger (a low-level, growing discomfort that builds over hours since your last meal) is the type semaglutide gradually quietens, particularly at higher doses. The kind that feels sharp and urgent thirty minutes after a meal, or that appears the moment you see food on screen, is usually something else.

Protein is the most reliable lever here. Meals built around adequate protein (eggs, fish, chicken, pulses, Greek yogurt) tend to create a longer sense of satiety even when appetite suppression from the medicine is only partial. Refined carbohydrates do the opposite: they digest quickly, blood sugar rises and dips, and hunger returns faster than it would after a protein-led meal. This isn't specific to Wegovy (it's basic metabolism) but it becomes more noticeable when you're paying attention to hunger signals for the first time.

Hydration is the other thing people underestimate. Thirst and mild hunger share similar signalling, and dehydration is genuinely common on GLP-1 medicines, especially if nausea has reduced your fluid intake. A glass of water before concluding you're hungry is not bad advice.

For practical guidance on what tends to work well alongside semaglutide, the page on what to eat on Wegovy covers food choices that fit the reduced-appetite context. If you're at a higher dose and hunger is still more disruptive than you expected, that's worth raising at your next clinical review rather than assuming it's the medicine's ceiling.

When returning hunger means something to review

There's a specific scenario that catches people off guard: hunger that seemed to have reduced well, then came back. This is different from the early-stage experience above. If you've been at the 2.4mg maintenance dose for a number of weeks and appetite suppression that was working has started to diminish, a few things could explain it.

Sleep is the most underappreciated factor. Poor or shortened sleep measurably raises ghrelin (the hunger hormone) and lowers peptide YY (which signals fullness), effects that can partially counteract what semaglutide is doing. Chronic stress has a similar hormonal effect. Neither is something the medicine can fully offset.

The question of persistent hunger at maintenance dose is worth exploring in more detail if this matches your situation. Physiological adaptation to the dose is another possibility your prescriber can assess; it's one of the reasons clinical review before repeat prescriptions isn't a formality.

Some people find that splitting their daily calories differently (eating more earlier in the day and less in the evening) works better with the way semaglutide affects their appetite curve. This varies by individual. It's not a dosing question, so it sits outside what a page like this can prescribe; your prescriber or a registered dietitian can help you think it through for your specific pattern.

If you're also exploring the cost side of treatment, the Wegovy price comparison page explains what private prescriptions typically include in the UK. And for a full picture of what the medicine involves, the Wegovy overview covers licensing, eligibility and access routes in one place.

What to do if hunger is affecting how you feel about treatment

Frustration at this stage is understandable. You're taking a weekly injection, navigating side effects, adjusting your eating habits, and hunger is still turning up uninvited. That deserves a direct response rather than reassurance that things will improve.

First: contact your prescriber if this is significantly affecting you. At nume, aftercare runs seven days a week for exactly this reason. Hunger that makes treatment feel unsustainable is a clinical conversation, not a waiting game.

Second: the people who tend to report the clearest appetite suppression on Wegovy share a few habits, consistent meal timing, high protein across the day, enough sleep, and limited ultra-processed food. These don't replace the medicine; they work with it.

Third: consider whether this is a dose-timing question. A small number of people find hunger increases noticeably in the 24–48 hours before their next injection is due. If that pattern sounds familiar, it's worth mentioning to your prescriber. Some people on the 2.4mg weekly injection have reported the experience of feeling almost no appetite at all at peak, then a return as the week progresses, the variation within a week is real.

Treatment decisions, including any dose adjustments, are always made by a clinician who reviews your full picture. If you'd like to discuss your experience with our prescribers, starting a free consultation is the first step.